Amydis, Inc.
Los Angeles, US · Delaware corporation · 1 known investors
Find your way into Amydis, Inc.
414 people in our graph share verified history with the Amydis, Inc. team — schools, employers, funds. One of them is your warm intro.
Anthony Linunlockedknows Stella Sarraf · together at University of California, Berkeley (overlapped)
×6knows the team · via University of California, Berkeley
×4knows the team · via Columbia University
knows the team · via Foresite Capital
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
Founders & leadership
SS
JK
James KhodabakhshNamed on SEC filing
MT
Mervyn TurnerNamed on SEC filing
FC
Faith CharlesNamed on SEC filing
Board
CA)
Investors · 1
Reported raises · per SEC filings
Form D private placements$14.7M disclosed across 3 rounds · 2022–2023
▶$3MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christine AylwardDirector
- Mervyn TurnerDirector
- Stella SarrafExecutive Officer, Director
- James KhodabakhshDirector
- Jerre L. SteadDirector
- Jack Thrift, CPAExecutive Officer
- Offering amount
- $6M
- Amount sold
- $3M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mervyn TurnerDirector
- Jerre L. SteadDirector
- Christine AylwardDirector
- James KhodabakhshDirector
- Stella SarrafExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedApr 2022 · 14 investors · BiotechnologyRule 506(b)
▶$5.7MraisedApr 2022 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stella SarrafExecutive Officer, Director
- James KhodabakhshDirector
- Mervyn TurnerDirector
- Christine AylwardDirector
- Faith CharlesDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Doximity28 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Practo14 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Sharecare9 shared keywordsSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
Companies competing with Amydis, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Amydis, Inc. do?
- Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
- Who founded Amydis, Inc.?
- Amydis, Inc. was founded by Stella Sarraf.
- Who are Amydis, Inc.'s investors?
- Amydis, Inc.'s investors include Magnetic Ventures.
- How much funding has Amydis, Inc. raised?
- Amydis, Inc. has disclosed $14.7M raised across 3 rounds.
- Where is Amydis, Inc. headquartered?
- Amydis, Inc. is headquartered in Los Angeles, US.